News

Twenty-year-old Jack Owens embarked on his 3,600-mile bike ride on May 20 and will end it on July 6 at the 34th Street Beach ...
A new study has found that people who don't smoke can still get lung cancer due to things like air pollution, harmful chemicals, and certain traditional herbal medicines.'We're ...
Originally appeared on E! Online Kathy Griffin is going au naturel. No joke, the comedian was ...
Earlier diagnoses and advancements in treatment options are providing hope for patients with endometrial cancer like Yaca.
NEW YORK – The US Food and Drug Administration on Wednesday granted accelerated approval to Dizal's oral EGFR inhibitor Zegfrovy (sunvozertinib) as a treatment for patients with locally advanced or ...
Shares of Summit Therapeutics jumped 9% Thursday on a report that it was discussing a lucrative partnership deal with ...
Kansas City, Kansas, residents are suing Harcros Chemicals, accusing the company of poisoning the air for decades with a ...
Researchers at McMaster University, Cleveland Clinic and Case Comprehensive Cancer Center have uncovered how a protein long ...
-- AstraZeneca is in talks with Summit Therapeutics for a deal in which it could pay as much as $15 billion over time to license a lung-cancer drug, Bloomberg reported Thursday, citing people familiar ...
Serious conditions behind bloody cough symptoms revealed. Life-threatening diseases that cause alarming blood in cough ...
The approval of sunvozertinib, an oral irreversible EGFR inhibitor, was supported by data from the WU-KONG1B trial (ClinicalTrials.gov Identifier: NCT03974022 ). The primary efficacy population ...
An investigational oral targeted therapy, zipalertinib (CLN-081), demonstrated meaningful tumor responses and a manageable ...